Richard J Travers - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Science Translational Medicine|October 31, 2014

Affinity-based design of a synthetic universal reversal agent for heparin anticoagulantsRajesh A Shenoi, Manu Thomas Kalathottukaren, Richard J Travers, et al.

Blood Advances|January 4, 2018

Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopeniaDouglas B Cines, Serge V Yarovoi, Sergei V Zaitsev, et al.

Clinical Science (London, England : 1979)|September 16, 2024

Identifying mitigating strategies for endothelial cell dysfunction and hypertension in response to VEGF receptor inhibitorsNicholas D Camarda, Qing Lu, Dawn M Meola, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Science Translational Medicine|October 31, 2014

Affinity-based design of a synthetic universal reversal agent for heparin anticoagulantsRajesh A Shenoi, Manu Thomas Kalathottukaren, Richard J Travers, et al.

Blood Advances|January 4, 2018

Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopeniaDouglas B Cines, Serge V Yarovoi, Sergei V Zaitsev, et al.

Clinical Science (London, England : 1979)|September 16, 2024

Identifying mitigating strategies for endothelial cell dysfunction and hypertension in response to VEGF receptor inhibitorsNicholas D Camarda, Qing Lu, Dawn M Meola, et al.

Pageof 2